A veteran nanotech scientist invents a genetic the rapeutic drug to treat diseases of ageing.
Some ideas, such as submarines, airplanes and satellites, have transformed the world. Others, such as cloning a dinosaur from their fossilised remains, have proved to be a distant dream. But at times, fantasies seep into reality. So, what if you were to live a thousand years like King Yayati from the Mahabharata? If nano technology scientist V.K. Tripathi is to be believed, it would soon be a reality well, if not a thousand years, you can, at least, add a few quality years to your life.
Resveratrol XAR is a wonder molecule that, according to Tripathi, can alter the genetic code and revitalise cells to ward off chronic age-related diseases. In fact, he claims to have succeeded in what big multinational pharmaceutical companies could not achieve after spending billions of dollars in genetech research. The breakthrough invention a nanotechnology based delivery mechanism that significantly increases the absorption of a genetech molecule within the nucleus of cells had been a big challenge for the scientific community. The molecule delivers resveratrol, which activates the Sirtuin and P53 genes the master guardian genes inside our cells that suppress tumour formation and have shown therapeutic benefits. This was revealed during clinical studies on about 2,000 patients in India over the past four-five years.
This story is from the October 23, 2016 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the October 23, 2016 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
"Focus on the challenge of each customer"
SHASHANK KUMAR MD & CO-FOUNDER I RAZORPAY Razorpay is India's first full-stack financial solutions company
PEDAL ON THE FUTURE
THE MG WINDSOR EV, WITH ITS FUTURISTIC AND MINIMALIST DESIGN, COMBINES THE BEST OF BOTH WORLDS-COMFORT AND TECHNOLOGY
BREATHE EASY
Whether you're battling allergies, looking to remove pollutants, or simply want to breathe easier, the right air purifier can make a difference
The Taste of India in a Glass
FROM ROYAL LIQUEURS TO DISTILLED MAHUA, INDIAN HERITAGE ALCOHOLIC BEVERAGES ARE HAVING THEIR DAY IN THE SUN
LOOK BEFORE YOU LEAP
IN 2025, INVESTORS WILL NEED TO FACTOR IN VOLATILITY ACROSS ASSET CLASSES
MISSING ADVISORS
INDIA HAS JUST ONE INVESTMENT ADVISOR FOR NEARLY EVERY 200,000 INVESTORS. AT A TIME WHEN RETAIL PARTICIPATION IN THE STOCK MARKETS IS BOOMING, THIS ASSUMES SIGNIFICANCE
TURNING A CORNER
SHARED ELECTRIC MOBILITY START-UP YULU'S SHIFT TO SERVICING THE QUICK COMMERCE SECTOR IS HELPING IT GROW FAST. IT IS NOW FOCUSSING ON IMPROVING ROAD SAFETY FEATURES AS IT TURNS EBITDA POSITIVE
REALITY CHECK
INDIAN STOCK MARKETS PLUNGED BEGINNING OCTOBER FOR A HOST OF REASONS, INCLUDING A FALL IN FII OWNERSHIP. HOW DEEP WILL THE CORRECTION BE?
TRUMP'S TRADE TANGO
The return of Donald Trump as the 47th President of the US has put the global economy on edge. India, too, is unlikely to remain unaffected. How will policymakers meet this latest challenge?
"The essence of the Trump administration will be transactional”
Global investor, analyst, and best-selling author Ruchir Sharma decodes why Donald Trump won the elections, what India should do, the risks, and more